Literature DB >> 11998912

The effectiveness of octreotide in the treatment of post-operative chylothorax.

Luca Rosti1, Roberta M Bini, Massimo Chessa, Gianfranco Butera, Manuela Drago, Mario Carminati.   

Abstract

UNLABELLED: Chylothorax may be spontaneous or a complication of thoracic surgery. Treatment of this potentially harmful condition is not well established and may comprise dietary interventions and surgery. Somatostatin seems effective in the management of chylothorax, although its mechanism of action is unclear.
CONCLUSION: octreotide, a somatostatin analogue, may be effective in the treatment of post-operative chylothorax.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11998912     DOI： 10.1007/s00431-001-0891-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  11 in total

1.  Somatostatin treatment of spontaneous chylothorax in an extremely low birth weight infant.

Authors:  Ryszard Lauterbach; Bozena Sczaniecka; Justyna Koziol; Marta Knapczyk
Journal:  Eur J Pediatr       Date:  2004-12-21       Impact factor: 3.183

2.  Octreotide in the management of postoperative chylothorax.

Authors:  L Rosti; F De Battisti; G Butera; S Cirri; M Chessa; A Delogu; M Drago; A Giamberti; G Pomè; M Carminati; A Frigiola
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

3.  Chylothorax in congenital diaphragmatic hernia.

Authors:  Alejandro Zavala; José-Manuel Campos; Cecilia Riutort; Ilona Skorin; Loreto Godoy; Miriam Faunes; Javier Kattan
Journal:  Pediatr Surg Int       Date:  2010-08-01       Impact factor: 1.827

4.  Congenital chylothorax treated with octreotide.

Authors:  Yasin Sahin; Derya Aydin
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

5.  Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review.

Authors:  João Moreira-Pinto; Paula Rocha; Angélica Osório; Berta Bonet; Fátima Carvalho; Carlos Duarte; Luísa Oliveira
Journal:  Pediatr Surg Int       Date:  2010-09-07       Impact factor: 1.827

6.  Octreotide for chylous effusions in congenital diaphragmatic hernia.

Authors:  Melissa W Landis; Dawn Butler; Foong Yen Lim; Sundeep Keswani; Jason Frischer; Beth Haberman; Paul S Kingma
Journal:  J Pediatr Surg       Date:  2013-11       Impact factor: 2.545

Review 7.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

8.  Postoperative chylothorax development is associated with increased incidence and risk profile for central venous thromboses.

Authors:  M A McCulloch; M R Conaway; J A Haizlip; M L Buck; V E Bovbjerg; T R Hoke
Journal:  Pediatr Cardiol       Date:  2007-11-21       Impact factor: 1.655

9.  Successful management of a bilateral diaphragmatic lymphangioma.

Authors:  Yung-Ching Ming; Kin-Sun Wong; Chao-Jan Wang; Jin-Yao Lai
Journal:  Pediatr Surg Int       Date:  2006-10-17       Impact factor: 2.003

10.  Therapeutic applications of octreotide in pediatric patients.

Authors:  Abdulrahman Al-Hussaini; Decker Butzner
Journal:  Saudi J Gastroenterol       Date:  2012 Mar-Apr       Impact factor: 2.485
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.